|
|
 |
|
| | |
| | | | | | | |
modification
|
|
PR:000037069 |
glycoprotein
|
Prot/GlycoRes+
|
"A protein that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000279 |
follistatin isoform 1, signal peptide removed glycosylated form
|
FST/iso:1/SigPep-/GlycoRes+
|
"A follistatin isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000434 |
follistatin isoform 1 cleaved and N-glycosylated 2
|
FST/iso:1/ClvNGlyco:2
|
"A follistatin isoform 1, signal peptide removed glycosylated form that has had the C-terminal residues up to, but not including, the acidic region removed, and has been N-glycosylated at residues equivalent to Asn-124 and Asn-288 of the amino acid sequence represented by UniProtKB:P10669-1. Example: UniProtKB:P10669-1, 30-332, Asn-124/Asn-288, MOD:00160." [PMID:8340384, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036413 |
follistatin isoform 1 cleaved and N-glycosylated 2 (pig)
|
pig-FST/iso:1/ClvNGlyco:2
|
"A follistatin isoform 1 cleaved and N-glycosylated 2 in pig. UniProtKB:P10669-1, 30-332, Asn-124/Asn-288, MOD:00160." [PMID:8340384, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036414 |
follistatin isoform 1 cleaved and N-glycosylated 2 (human)
|
hFST/iso:1/ClvNGlyco:2
|
"A follistatin isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P19883-1, 30-332, Asn-124/Asn-288, MOD:00160." [PMID:16150905, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036412 |
follistatin isoform 1, signal peptide removed glycosylated form (human)
|
hFST/iso:1/SigPep-/GlycoRes+
|
"A follistatin isoform 1, signal peptide removed glycosylated form in human. UniProtKB:P19883-1, 30-344, MOD:00693." [PMID:16150905, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036414 |
follistatin isoform 1 cleaved and N-glycosylated 2 (human)
|
hFST/iso:1/ClvNGlyco:2
|
"A follistatin isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P19883-1, 30-332, Asn-124/Asn-288, MOD:00160." [PMID:16150905, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000280 |
follistatin isoform 2, signal peptide removed glycosylated form
|
FST/iso:2/SigPep-/GlycoRes+
|
"A follistatin isoform 2, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036415 |
follistatin isoform 2, signal peptide removed N-glycosylated 1 (human)
|
hFST/iso:2/SigPep-/NGlyco:1
|
"A follistatin isoform 2, signal peptide removed glycosylated form that is in human and has been N-glycosylated at residues equivalent to Asn-124 and Asn-288 of the amino acid sequence represented by UniProtKB:P19883-2. UniProtKB:P19883-2, 30-317, Asn-124/Asn-288, MOD:00160." [PMID:15454184, PMID:16150905, PMID:1906804, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036416 |
follistatin isoform 2, signal peptide removed N-glycosylated 1 (pig)
|
pig-FST/iso:2/SigPep-/NGlyco:1
|
"A follistatin isoform 2, signal peptide removed glycosylated form that is in pig and has been N-glycosylated at residues equivalent to Asn-124 and Asn-288 of the amino acid sequence represented by UniProtKB:P10669-2. UniProtKB:P10669-2, 30-317, Asn-124/Asn-288, MOD:00160." [PMID:8340384, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000414 |
activin receptor type-2A isoform 1 glycosylated and phosphorylated form
|
ACVR2A/iso:1/GlycoPhos+
|
"An activin receptor type-2A isoform 1 that includes at least one glycosylated residue and at least one phosphorylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000528 |
activin receptor type-2A isoform 1 glycosylated and phosphorylated 1
|
ACVR2A/iso:1/GlycoPhos:1
|
"An activin receptor type-2A isoform 1 glycosylated and phosphorylated form in which the phosphorylation occurs at Ser/Thr residues. This constitutes the active receptor subunit." [PMID:8395525]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036440 |
activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 (mouse)
|
mACVR2A/iso:1/GlycoPhos:1
|
"An activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 in mouse." [PMID:10452853, PMID:11459935, PMID:12414726, PMID:16991118, PMID:7885474, PMID:8395525, PMID:8612709, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036441 |
activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 (human)
|
hACVR2A/iso:1/GlycoPhos:1
|
"An activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 in human." [PMID:12665502, PMID:1314589, PMID:8622651, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000415 |
activin receptor type-2B isoform ActR-IIB2 glycosylated and phosphorylated form
|
ACVR2B/iso:ActR-IIB2/GlycoPhos+
|
"An activin receptor type-2B isoform ActR-IIB2 that includes at least one glycosylated residue and at least one phosphorylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000529 |
activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1
|
ACVR2B/iso:ActR-IIB2/NGlycoPhos:1
|
"An activin receptor type-2B isoform ActR-IIB2 glycosylated and phosphorylated form in which the phosphorylation occurs at Ser/Thr residues within the GS-motif, and constitutes an active activin receptor subunit." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036442 |
activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 (mouse)
|
mACVR2B/iso:ActR-IIB2/NGlycoPhos:1
|
"An activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 in mouse." [PMID:10452853, PMID:11459935, PMID:12414726, PMID:1326537, PMID:16991118, PMID:8721982, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036443 |
activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 (human)
|
hACVR2B/iso:ActR-IIB2/NGlycoPhos:1
|
"An activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 in human." [PMID:11279102, PMID:24337809, PMID:8161782, PMID:8622651, PMID:9872992, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000419 |
Muellerian-inhibiting factor isoform 1 cleaved and glycosylated form
|
AMH/iso:1/ClvGlyco+
|
"A Muellerian-inhibiting factor isoform 1 cleaved 1 that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000534 |
Muellerian-inhibiting factor isoform 1 cleaved and glycosylated 2
|
AMH/iso:1/ClvGlyco:2
|
"A Muellerian-inhibiting factor isoform 1 cleaved and glycosylated form that has been cleaved at the RxxR dibasic cleavage site rendering the propeptide and the mature protein non-covalently bound." [PMID:14673134]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036444 |
Muellerian-inhibiting factor isoform 1 cleaved and N-glycosylated 2 (human)
|
hAMH/iso:1/ClvNGlyco:2
|
"A Muellerian-inhibiting factor isoform 1 cleaved and glycosylated 2 in human, in which the cleaved parts remain joined by disulfide bonds. The position(s) of glycosylation sites have not been experimentally determined. UniProtKB:P03971-1, 26-450, 451-560, MOD:00160." [PMID:12834017, PMID:14673134, PMID:14750901, PMID:3754790, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000421 |
c-myc protein isoform 1 glycosylated form
|
MYC/iso:1/GlycoRes+
|
"A c-myc protein isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000536 |
c-myc protein isoform 1 O-glycosylated 1
|
MYC/iso:1/OGlyco:1
|
"A c-myc protein isoform 1 glycosylated form that has been O-glycosylated at the Thr residue within the L[LY]PTLTPPLS sequence of the Myc box I within the amino-terminal regulatory domain. Example: UniProtKB:P01106-1, Thr-58, MOD:00806." [PMID:11904304, PMID:7642555]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000026051 |
c-myc protein isoform 1 O-glycosylated 1 (human)
|
hMYC/iso:1/OGlyco:1
|
"A c-myc protein isoform 1 O-glycosylated 1 in human. UniProtKB:P01106-1, Thr-58, MOD:00806." [PMID:11904304, PMID:7642555]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000429 |
decorin isoform A cleaved and glycosylated form
|
DCN/iso:A/ClvGlyco+
|
"A decorin isoform A, signal peptide removed form that has had the propeptide removed and that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000545 |
decorin isoform A cleaved and glycosylated 1
|
DCN/iso:A/ClvGlyco:1
|
"A decorin isoform A cleaved and glycosylated form that has been modified with O-linked glycosaminoglycan at the most N-terminal SG site and additional N-linked glycosylated Asn residues. Example: UniProtKB:P07585-1, 31-359, Ser-34, MOD:00814|Asn-211/Asn-262/Asn-303, MOD:00160." [PMID:16258169, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036457 |
decorin isoform A cleaved and glycosylated 1 (human)
|
hDCN/iso:A/ClvGlyco:1
|
"A decorin isoform A cleaved and glycosylated 1 in human. UniProtKB:P07585-1, 31-359, Ser-34, MOD:00814|Asn-211/Asn-262/Asn-303, MOD:00160." [PMID:16258169, PMID:17651433, PMID:9988678, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000432 |
tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form
|
FASLG/iso:FasL/GlycoRes+
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000546 |
tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1
|
FASLG/iso:FasL/NGlyco:1
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form that has been N-glycosylated at the Asn residues within the N-glycosylation sites located in the C-terminal extracellular region. Example: UniProtKB:P48023-1, Asn-184/Asn-250/Asn-260, MOD:00160." [PMID:9405425]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036458 |
tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human)
|
hFASLG/iso:FasL/NGlyco:1
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 in human. UniProtKB:P48023-1, Asn-184/Asn-250/Asn-260, MOD:00160." [PMID:9405425, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000446 |
interferon gamma isoform 1, signal peptide removed glycosylated form
|
IFNG/iso:1/SigPep-/GlycoRes+
|
"An interferon gamma isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PMID:3109913, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000447 |
interferon gamma isoform 1 cleaved and N-glycosylated 2
|
IFNG/iso:1/ClvNGlyco:2
|
"An interferon gamma isoform 1, signal peptide removed glycosylated form that is a mature protein with N-linked glycosylation and partial proteolytic degradation of the C-terminus. Example: UniProtKB:P01579-1, 24-161, Asn-48/Asn-120, MOD:00160." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036420 |
interferon gamma isoform 1 cleaved and N-glycosylated 2 (human)
|
hIFNG/iso:1/ClvNGlyco:2
|
"An interferon gamma isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P01579-1, 24-161, Asn-48/Asn-120, MOD:00160." [PMID:1902591, PMID:6427223, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036407 |
interferon gamma isoform 1, signal peptide removed glycosylated form (mouse)
|
mIFNG/iso:1/SigPep-/GlycoRes+
|
"An interferon gamma isoform 1, signal peptide removed glycosylated form in mouse. UniProtKB:P01580-1, 23-155, MOD:00693." [PMID:11027433, PMID:11057672, PMID:11728336, PMID:12882831, PMID:12925700, PMID:15240714, PMID:15240719, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036419 |
interferon gamma isoform 1, signal peptide removed N-glycosylated 1 (human)
|
hIFNG/iso:1/SigPep-/NGlyco:1
|
"An interferon gamma isoform 1, signal peptide removed glycosylated form in human in which N-linked glycosylation occurs at Asn-48 and Asn-120. UniProtKB:P01579-1, 24-157, Asn-48/Asn-120, MOD:00160." [PMID:10986460, PMID:3109913, PMID:6427223, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000485 |
thrombospondin-1 isoform 1 cleaved and glycosylated form
|
THBS1/iso:1/ClvGlyco+
|
"A thrombospondin-1 isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000590 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated form
|
THBS1/iso:1/Clv:2/GlycoRes+
|
"A thrombospondin-1 isoform 1 cleaved and glycosylated form that has been proteolytically processed by ADAMTS1 to render a C-terminal domain product." [PMID:17082774]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036489 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated 1 (human)
|
hTHBS1/iso:1/Clv:2/Glyco:1
|
"A thrombospondin-1 isoform 1 cleaved 2 glycosylated form in human and that has been post-translationally modified at four Trp residues, one Ser residue, and two Thr residues. UniProtKB:P07996-1, 312-1170, Trp-385/Trp-438/Trp-441/Trp-498, MOD:00222|Ser-394, MOD:00812|Thr-450/Thr-507, MOD:00813." [PMID:11067851, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036490 |
thrombospondin-1 isoform 1 cleaved 2 glycosylated form (mouse)
|
mTHBS1/iso:1/Clv:2/GlycoRes+
|
"A thrombospondin-1 isoform 1 cleaved 2 glycosylated form in mouse. UniProtKB:P35441-1, 312-1170, MOD:00693." [PMID:17082774, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000492 |
transcription factor Sp1 isoform 1 glycosylated form
|
SP1/iso:1/GlycoRes+
|
"A transcription factor Sp1 isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000598 |
transcription factor Sp1 isoform 1 O-glycosylated 1
|
SP1/iso:1/OGlyco:1
|
"A transcription factor Sp1 isoform 1 glycosylated form that has terminal O-linked N-acetylglucosamines. Example: UniProtKB:P08047-1, Ser-491, MOD:00805." [PMID:11371615, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036498 |
transcription factor Sp1 isoform 1 O-glycosylated 1 (human)
|
hSP1/iso:1/OGlyco:1
|
"A transcription factor Sp1 isoform 1 O-glycosylated 1 in human. UniProtKB:P08047-1, Ser-491, MOD:00805." [PMID:11371615, PMID:9343410, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000505 |
bone morphogenetic protein 7 isoform 1, mature glycosylated form
|
BMP7/iso:1/ClvGlyco+
|
"A bone morphogenetic protein 7 isoform 1, mature form that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000613 |
bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1
|
BMP7/iso:1/mature/NGlyco:1
|
"A bone morphogenetic protein 7 isoform 1, mature glycosylated form that is N-glycosylated at the N{P}[ST]{P} motif. This form is a disulfide linked homodimer. Example: UniProtKB:P18075-1, 293-431, Asn-372, MOD:00160." [PMID:15929982, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036517 |
bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 (human)
|
hBMP7/iso:1/mature/NGlyco:1
|
"A bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 in human. UniProtKB:P18075-1, 293-431, Asn-372, MOD:00160." [PMID:15047707, PMID:15929982, PMID:8570652, PMID:9872992, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036518 |
bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 (mouse)
|
mBMP7/iso:1/mature/NGlyco:1
|
"A bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 in mouse. UniProtKB:P23359-1, 292-430, Asn-371, MOD:00160." [PMID:14623234, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000614 |
bone morphogenetic protein 7 isoform 1, mature N-glycosylated 2
|
BMP7/iso:1/mature/NGlyco:2
|
"A bone morphogenetic protein 7 isoform 1, mature glycosylated form that has the propeptide still bound to the mature protein. This form is N-glycosylated at the most C-terminal N{P}[ST]{P} motif and is a homodimer. Example: UniProtKB:P18075-1, 20-292, 293-431, Asn-372, MOD:00160." [PMID:15929982]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036519 |
bone morphogenetic protein 7 isoform 1, mature N-glycosylated 2 (human)
|
hBMP7/iso:1/mature/NGlyco:2
|
"A bone morphogenetic protein 7 isoform 1, mature N-glycosylated 2 in human, in which the cleaved parts remain joined by disulfide bonds. UniProtKB:P18075-1, 20-292, 293-431, Asn-372, MOD:00160." [PMID:15929982, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000935 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 glycosylated form
|
HCN1/iso:1/GlycoRes+
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000984 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 N-glycosylated 1
|
HCN1/iso:1/NGlyco:1
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 glycosylated form with N-glycosylation at the N-linked glycosylation consensus sequence (Nx[ST]) in the extracellular domain between S5 and S6 transmembrane segments. Example: UniProtKB:O88704-1, Asn-327, MOD:00160." [PMID:17988239]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036573 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 N-glycosylated 1 (mouse)
|
mHCN1/iso:1/NGlyco:1
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 N-glycosylated 1 in mouse. UniProtKB:O88704-1, Asn-327, MOD:00160." [PMID:12928435, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000936 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 glycosylated form
|
HCN2/iso:1/GlycoRes+
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000985 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 N-glycosylated 1
|
HCN2/iso:1/NGlyco:1
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 glycosylated form with N-glycosylation at the N-linked glycosylation consensus sequence (Nx[ST]) in the extracellular domain between S5 and S6 transmembrane segments. Example: UniProtKB:O88703-1, Asn-380, MOD:00160." [PMID:12928435]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036574 |
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 N-glycosylated 1 (mouse)
|
mHCN2/iso:1/NGlyco:1
|
"A potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 N-glycosylated 1 in mouse. UniProtKB:O88703-1, Asn-380, MOD:00160." [PMID:12928435, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000989 |
voltage-gated potassium channel KCNH2 isoform A glycosylated form
|
KCNH2/iso:A/GlycoRes+
|
"A voltage-gated potassium channel KCNH2 isoform A that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000998 |
voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1
|
KCNH2/iso:A/NGlyco:1
|
"A voltage-gated potassium channel KCNH2 isoform A glycosylated form that has been glycosylated at the Asn residue within the Nx[T/S] motif located approximately 26 amino acids downstream of the S5 transmembrane domain. Example: UniProtKB:Q12809-1, Asn-598, MOD:00160." [PMID:12063277]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036581 |
voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 (human)
|
hKCNH2/iso:A/NGlyco:1
|
"A voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 in human. UniProtKB:Q12809-1, Asn-598, MOD:00160." [PMID:12063277, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036582 |
voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 (mouse)
|
mKCNH2/iso:A/NGlyco:1
|
"A voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 in mouse. UniProtKB:O35219-1, Asn-600, MOD:00160." [PMID:14668215, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001048 |
cftr isoform 1 glycosylated form
|
CFTR/iso:1/GlycoRes+
|
"A cftr isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001049 |
cftr isoform 1 N-glycosylated 1
|
CFTR/iso:1/NGlyco:1
|
"A cftr isoform 1 glycosylated form in which the glycosylation is at two Asn residues within the N{P}[ST]{P} motif, located in the fourth extracellular loop. Example: UniProtKB:P13569-1, Asn-894/Asn-900, MOD:00160." [PMID:7518437]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036593 |
cftr isoform 1 N-glycosylated 1 (human)
|
hCFTR/iso:1/NGlyco:1
|
"A cftr isoform 1 N-glycosylated 1 in human. UniProtKB:P13569-1, Asn-894/Asn-900, MOD:00160." [PMID:7518437, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001723 |
transient receptor potential cation channel TRPM8 isoform 1 glycosylated form
|
TRPM8/iso:1/GlycoRes+
|
"A transient receptor potential cation channel TRPM8 isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001724 |
transient receptor potential cation channel TRPM8 isoform 1 N-glycosylated 1
|
TRPM8/iso:1/NGlyco:1
|
"A transient receptor potential cation channel TRPM8 isoform 1 glycosylated form that has been N-glycosylated on the Asn consensus N-glycosylation site within the pore loop region. Example: UniProtKB:Q8R4D5-1, Asn-934, MOD:00160." [PMID:17015441]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036607 |
transient receptor potential cation channel TRPM8 isoform 1 N-glycosylated 1 (mouse)
|
mTRPM8/iso:1/NGlyco:1
|
"A transient receptor potential cation channel TRPM8 isoform 1 N-glycosylated 1 in mouse. UniProtKB:Q8R4D5-1, Asn-934, MOD:00160." [PMID:17015441, PRO:HJD]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001737 |
inhibin alpha chain isoform 1 glycosylated form
|
INHA/iso:1/GlycoRes+
|
"An inhibin alpha chain isoform 1 that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001732 |
inhibin alpha chain isoform 1 cleaved and glycosylated form
|
INHA/iso:1/ClvGlyco+
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001733 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
|
INHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001736 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
|
INHA/iso:1/ClvNGlyco:1
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001738 |
inhibin alpha chain isoform 1 N-glycosylated 1
|
INHA/iso:1/NGlyco:1
|
"An inhibin alpha chain isoform 1 glycosylated form that is N-glycosylated at the Asn residue within the conserved N-glycosylation consensus site within the alphan N-terminal region, and in the first (or unique) consensus N-glycosylation site in the alpha C-terminal region. This is a glycosylated precursor for the mature inhibin alpha. Example: UniProtKB:P05111-1, Asn-146/Asn-268, MOD:00160." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036610 |
inhibin alpha chain isoform 1 N-glycosylated 1 (human)
|
hINHA/iso:1/NGlyco:1
|
"An inhibin alpha chain isoform 1 N-glycosylated 1 in human. UniProtKB:P05111-1, Asn-146/Asn-268, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001739 |
inhibin alpha chain isoform 1 N-glycosylated 2
|
INHA/iso:1/NGlyco:2
|
"An inhibin alpha chain isoform 1 glycosylated form that is N-glycosylated at the Asn residue located in the conserved N-glycosylation consensus site within the alphan N-terminal region, and at the Asn residues within the two consensus N-glycosylation sites within the alpha C-terminal region. This is a glycosylated precursor for the mature inhibin alpha. Example: UniProtKB:P05111-1, Asn-146/Asn-268/Asn-302, MOD:00160." [PMID:17456790]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036611 |
inhibin alpha chain isoform 1 N-glycosylated 2 (human)
|
hINHA/iso:1/NGlyco:2
|
"An inhibin alpha chain isoform 1 N-glycosylated 2 in human. UniProtKB:P05111-1, Asn-146/Asn-268/Asn-302, MOD:00160." [PMID:17456790, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001792 |
prominin-1 isoform 6 glycosylated form
|
PROM1/iso:6/GlycoRes+
|
"A prominin-1 isoform 6 that includes at least one glycosylated residue." [PRO:HJD]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001793 |
prominin-1 isoform 3 glycosylated form
|
PROM1/iso:3/GlycoRes+
|
"A prominin-1 isoform 3 that includes at least one glycosylated residue." [PRO:HJD]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003018 |
prostate-specific antigen isoform 1 cleaved and glycosylated form
|
KLK3/iso:1/ClvGlyco+
|
"A prostate-specific antigen isoform 1, signal peptide removed form that has had the propeptide removed and that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003019 |
prostate-specific antigen isoform 1 cleaved and N-glycosylated 1
|
KLK3/iso:1/ClvNGlyco:1
|
"A prostate-specific antigen isoform 1 cleaved and glycosylated form that contains an N-glycosylated Asn residue within the glycosylation consensus sequence near its N terminus. Example: UniProtKB:P07288-1, 25-261, Asn-69, MOD:00160." [PMID:2422647, PMID:3691515, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003081 |
neuropilin-1 isoform 1, signal peptide removed glycosylated form
|
NRP1/iso:1/SigPep-/GlycoRes+
|
"A neuropilin-1 isoform 1, signal peptide removed form that has been post-translationally modified to include a glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003082 |
neuropilin-1 isoform 1, signal peptide removed O-glycosylated 1
|
NRP1/iso:1/SigPep-/OGlyco:1
|
"A neuropilin-1 isoform 1, signal peptide removed glycosylated form that has a heparan sulfate moiety on a Ser residue located in the region between the F5/8 type C domain (Pfam:PF00754) and the MAM domain (Pfam:PF00629). Example: UniProtKB:O14786-1, 22-923, Ser-612, MOD:00215." [PMID:16763549, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036631 |
neuropilin-1 isoform 1, signal peptide removed O-glycosylated 1 (human)
|
hNRP1/iso:1/ClvOGlyco:1
|
"A neuropilin-1 isoform 1, signal peptide removed O-glycosylated 1 in human. UniProtKB:O14786-1, 22-923, Ser-612, MOD:00215." [PMID:16763549, PRO:JAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003083 |
neuropilin-1 isoform 1, signal peptide removed O-glycosylated 2
|
NRP1/iso:1/SigPep-/OGlyco:2
|
"A neuropilin-1 isoform 1, signal peptide removed glycosylated form that has a chondroitin sulfate moiety on a Ser residue located in the region between the F5/8 type C domain (Pfam:PF00754) and the MAM domain (Pfam:PF00629). Example: UniProtKB:O14786-1, 22-923, Ser-612, MOD:00213." [PMID:16763549, PRO:JAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036632 |
neuropilin-1 isoform 1, signal peptide removed O-glycosylated 2 (human)
|
hNRP1/iso:1/ClvOGlyco:2
|
"A neuropilin-1 isoform 1, signal peptide removed O-glycosylated 2 in human. UniProtKB:O14786-1, 22-923, Ser-612, MOD:00213." [PMID:16763549, PRO:JAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003227 |
HIV envelope glycoprotein gp160 glycosylated form
|
env/Clv:gp160/GlycoRes+
|
"An HIV envelope glycoprotein gp160 that includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003229 |
HIV envelope glycoprotein gp120 glycosylated form
|
env/Clv:gp120/GlycoRes+
|
"An HIV envelope glycoprotein gp160 glycosylated form that is the N-terminal product of proteolytic processing by host furin or furin-like proteases." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000036935 |
HIV envelope glycoprotein gp120 N-glycosylated 1
|
env/Clv:gp120/NGlyco:1
|
"An HIV envelope glycoprotein gp120 glycosylated form that is glycosylated on residues equivalent to Asn-200, Asn-233, Asn-244, Asn-265, Asn-298, Asn-304, Asn-334, Asn-341, Asn-388, Asn-394, and Asn-400 of the amino acid sequence represented by UniProtKB:P03378. Example: UniProtKB:P03378, 32-509, Asn-200/Asn-233/Asn-244/Asn-265/Asn-298/Asn-304/Asn-334/Asn-341/Asn-388/Asn-394/Asn-400, MOD:00160." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036640 |
envelope glycoprotein gp120 glycosylated 1 (Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2))
|
env/Clv:gp120/NGlyco:1 (HV1A2)
|
"An HIV envelope glycoprotein gp120 N-glycosylated 1 in Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2). UniProtKB:P03378, 32-509, Asn-200/Asn-233/Asn-244/Asn-265/Asn-298/Asn-304/Asn-334/Asn-341/Asn-388/Asn-394/Asn-400, MOD:00160." [PMID:12438611, PMID:15043214, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000044791 |
envelope glycoprotein gp120 N-glycosylated 1 (Human immunodeficiency virus type 1 group M subtype B (isolate JRCSF))
|
HIV1(JRCSF)-env/Clv:gp120/NGlyco:1
|
"An HIV envelope glycoprotein gp120 N-glycosylated 1 in Human immunodeficiency virus type 1 group M subtype B (isolate JRCSF). UniProtKB:P20871, 31-503, Asn-195/Asn-228/Asn-239/Asn-260/Asn-293/Asn-299/Asn-329/Asn-336/Asn-382/Asn-388/Asn-392, MOD:00160." [PMID:12438611, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003230 |
HIV envelope glycoprotein gp41 glycosylated form
|
env/Clv:gp41/GlycoRes+
|
"An HIV envelope glycoprotein gp160 glycosylated form that is the C-terminal product of proteolytic processing by host furin or furin-like proteases. This cleaved form includes part of the extracellular domain, the transmembrane and the cytosolic domains." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003255 |
antithrombin-III isoform 1, signal peptide removed glycosylated form
|
SERPINC1/iso:1/SigPep-/GlycoRes+
|
"An antithrombin-III isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003256 |
antithrombin-III isoform 1, signal peptide removed glycosylated 1
|
SERPINC1/iso:1/SigPep-/Glyco:1
|
"An antithrombin-III isoform 1, signal peptide removed glycosylated form that has been N-glycosylated in the Asn residue within the four glycosylation patterns N{P}[ST]{P}." [PMID:17330941, UniProtKB:P01008]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003298 |
lymphocyte antigen 96 isoform 1, signal peptide removed glycosylated form
|
LY96/iso:1/SigPep-/GlycoRes+
|
"A lymphocyte antigen 96 isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA]
|
|
Yes |
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003299 |
lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1
|
LY96/iso:1/SigPep-/NGlyco:1
|
"A lymphocyte antigen 96 isoform 1, signal peptide removed glycosylated form that has been N-glycosylated at positions equivalent to Asn-26 and Asn-114 of the amino acid sequence represented by UniProtKB:Q9Y6Y9-1. Example: UniProtKB:Q9Y6Y9-1, 19-160, Asn-26/Asn-114, MOD:00160." [PMID:11593030, PMID:17569869, PRO:CNA, PRO:DAN, TLR:AMM]
|
|
Yes |
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000025786 |
lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 (human)
|
hLY96/iso:1/SigPep-/NGlyco:1
|
"A lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 in human. UniProtKB:Q9Y6Y9-1, 19-160, Asn-26/Asn-114, MOD:00160." [PMID:11593030, PMID:11706042, PMID:17569869, TLR:AMM]
|
Yes |
Yes |
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000027171 |
lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 (mouse)
|
mLY96/iso:1/SigPep-/NGlyco:1
|
"A lymphocyte antigen 96 isoform 1, signal peptide removed glycosylated form in mouse that has been N-glycosylated on Asn residues at positions 26, 114, and 150 of the amino acid sequence represented by UniProtKB:Q9JHF9-1. UniProtKB:Q9JHF9-1, 19-160, Asn-26/Asn-114/Asn-150, MOD:00160." [PMID:17803912, PRO:CNA]
|
Yes |
Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000021989 |
leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed glycosylated form
|
DLEC2/iso:1/SigPep-/GlycoRes+
|
"A leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000021957 |
leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed N-glycosylated 1
|
DLEC2/iso:1/SigPep-/NGlyco:1
|
"A leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed glycosylated form that has been N-glycosylated on residues equivalent to UniProtKB:P05087-1 Asn-32 and Asn-80. Example: UniProtKB:P05087-1, 21-272, Asn-32/Asn-80, MOD:00160." [UniProtKB:P05087]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025408 |
T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed glycosylated form
|
CD8A/iso:1/SigPep-/GlycoRes+
|
"A T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025409 |
T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed glycosylated form
|
CD8B/iso:1/SigPep-/GlycoRes+
|
"A T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025813 |
receptor-type tyrosine-protein phosphatase C isoform CD45RABC, signal peptide removed glycosylated form
|
PTPRC/iso:CD45R/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RABC, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025814 |
receptor-type tyrosine-protein phosphatase C isoform CD45RA, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RA/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RA, signal peptide removed form that includes at least one glycosylated residue." [PMID:1351092, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025815 |
receptor-type tyrosine-protein phosphatase C isoform CD45RB, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RB/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RB, signal peptide removed form that includes at least one glycosylated residue." [PMID:1351092, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025816 |
receptor-type tyrosine-protein phosphatase C isoform CD45RO, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RO/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RO, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025817 |
receptor-type tyrosine-protein phosphatase C isoform CD45RC, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RC/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RC, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025818 |
receptor-type tyrosine-protein phosphatase C isoform CD45RAB, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RAB/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RAB, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025819 |
receptor-type tyrosine-protein phosphatase C isoform CD45RAC, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RAC/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RAC, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025820 |
receptor-type tyrosine-protein phosphatase C isoform CD45RBC, signal peptide removed glycosylated form
|
PTPRC/iso:CD45RBC/SigPep-/GlycoRes+
|
"A receptor-type tyrosine-protein phosphatase C isoform CD45RBC, signal peptide removed form that includes at least one glycosylated residue." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | | |
organism-modification
|
|
PR:000037264 |
cochlin, signal peptide removed glycosylated form (mouse)
|
mCOCH/SigPep-/GlycoRes+
|
"A cochlin, signal peptide removed form (mouse) that includes at least one glycosylated residue. UniProtKB:Q62507, 26-552, MOD:00693." [PMID:23684986, PRO:KRC]
|
|
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000037262 |
cochlin p18 (mouse)
|
mCOCH/Clv:p18
|
"A cochlin, signal peptide removed form (mouse) that results from cleavage downstream of the LCCL domain (Pfam:PF03815), and includes at least one glycosylated residue. UniProtKB:Q62507, 26-134, MOD:00693." [PMID:23684986, PRO:KRC]
|
Yes |
|
|
|
|
|
| | | | |
| | | | | |
organism-modification
|
|
PR:000044792 |
interleukin-1 receptor-like 1 isoform B, signal peptide removed glycosylated form (mouse)
|
mIL1RL1/iso:B/SigPep-/GlycoRes+
|
"An interleukin-1 receptor-like 1 isoform B, signal peptide removed form (mouse) that has been post-translationally modified by N-glycosylation and sialylation. UniProtKB:P14719-2, 27-337, MOD:00693." [PMID:1532358, PRO:KRC]
|
|
|
|
|
